LENSAR, INC. Business Combination, Acquisition Related Costs
LENSAR, INC. (LNSR) reported Business Combination, Acquisition Related Costs of $8.13 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:BusinessCombinationAcquisitionRelatedCosts · last filed 2026-08-13
- LENSAR, INC. business combination, acquisition related costs for the quarter ending 2026-06-30 was -$524.00K, a 112.55% decline year-over-year.
- LENSAR, INC. business combination, acquisition related costs for the quarter ending 2026-03-31 was $8.66M, a 104.88% increase year-over-year.
- LENSAR, INC. business combination, acquisition related costs for the quarter ending 2025-12-31 was $3.47M.
- LENSAR, INC. business combination, acquisition related costs for the quarter ending 2025-09-30 was $5.28M.
- LENSAR, INC. business combination, acquisition related costs for fiscal 2025 was $17.14M.
| Period end | Business Combination, Acquisition Related Costs 3 month | Business Combination, Acquisition Related Costs 6 month | Business Combination, Acquisition Related Costs 9 month | Business Combination, Acquisition Related Costs 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$524.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $8.13M 10-Q · filed 2026-08-13 | $11.60M derived: sum of 3 quarters · filed 2026-08-13 | $16.87M derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $8.66M 10-Q · filed 2026-05-08 | $12.12M derived: sum of 2 quarters · filed 2026-05-08 | $17.40M derived: sum of 3 quarters · filed 2026-05-08 | $12.77M 10-Q · filed 2026-08-13 |
| 2025-12-31 | $3.47M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $8.74M derived: sum of 2 quarters · filed 2026-03-31 | $12.92M derived: sum of 3 quarters · filed 2026-08-13 | $17.14M 10-K · filed 2026-03-31 |
| 2025-09-30 | $5.28M 10-Q · filed 2025-11-06 | $9.45M derived: sum of 2 quarters · filed 2026-08-13 | $13.67M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $4.17M 10-Q · filed 2026-08-13 | $8.40M 10-Q · filed 2026-08-13 | ||
| 2025-03-31 | $4.22M 10-Q · filed 2026-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Apyx Medical Corp (APYX) | United States | $0.120B | -21.85 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B |